Skip to content

Sugammadex Dosage Based on Ideal Body Weight for Profound Rocuronium-induced Neuromuscular Blockade Reversal in Morbidly Obese Patients

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02545595
Enrollment
Unknown
Registered
2015-09-10
Start date
2012-05-31
Completion date
Unknown
Last updated
2016-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity

Keywords

General anaesthesia, Curarization with rocuronium

Brief summary

This randomized double blind clinical trial focuses on patients with Body Masse Index ≥ 40 kg/m2, undergoing scheduled surgery. Neuromuscular transmission monitoring at the adductor is performed using. Anaesthesia is induced with anaesthesic and maintained with curare. At the end of the procedure, patients with profound neuromuscular blockade receive either 1 mg/kg, 2 mg/kg or 4 mg/kg Sugammadex based on ideal body weight. A complete reversal failure is defined by a Train Of Four ratio \< 0.9 within 10 min after administration of Sugammadex or if recurarization occurs within 15 min after complete reversal success.

Interventions

Sponsors

Poitiers University Hospital
Lead SponsorOTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* General anaesthesia * Neuromuscular blockade induce by rocuronium * Body Masse Indice ≥ 40 kg/m2 * informed consent

Exclusion criteria

* Contraindication to rocuronium or sugammadex * Pregnant women * Severe renal insufficiency

Design outcomes

Primary

MeasureTime frameDescription
determine a profound neuromuscular blockade reversal on ideal body weight30 minutesA complete reversal failure is defined by a Train Of Four ratio \< 0.9 within 10 min after administration of Sugammadex or if recurarization occurs within 15 min after complete reversal success

Secondary

MeasureTime frame
Compare dosages based on ideal body weight to real body weight30 minutes

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026